Goodmeds Famotidine 20mg 500 count - Cabinet Health P.B.C.

Manufacturer
Cabinet Health P.B.C.
Effective date
2026-07-01
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
weekly-update
Hydrated at
2026-07-17 21:43:28

Label at a glance#

ProductGoodmeds Famotidine 20mg 500 count
Active ingredientFAMOTIDINE
Label structure16 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Famotidine USP 20mg

OTC - PURPOSE SECTION

Acid Reducer

INDICATIONS & USAGE SECTION

  • Relieves heartburn associated with acid indigestion and sour stomach
  • Prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to famotidine or other acid reducers

OTC - ACTIVE INGREDIENT SECTION

Allergy alert: Do not use if you are allergic to famotidine or other acid reducer

OTC - DO NOT USE SECTION

  • If you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
  • with other acid reducer

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have:

  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating, or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomit
  • stomach pain
  • kidney disease

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are:

  • taking a prescription drug. Acid reducers may interact with certain prescription drugs

OTC - STOP USE SECTION

Stop use and as a doctor if:

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

DOSAGE & ADMINISTRATION SECTION

Directions

adults and children 12 years and over:

  • to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
  • to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
  • do not use more than 2 tablets in 24 hours

children under 12 years:

  • ask a doctor

OTHER SAFETY INFORMATION

  • read the directions and warnings before use
  • safety sealed: do not use if imprinted foil under bottle cap is opened or torn
  • store at 20°–25°C (68°–77°F)
  • protect from moisture

OTC - QUESTIONS SECTION

Call 1-908-242-6108 Mon-Fri 8:00 AM to 5:00 PM EST

INACTIVE INGREDIENT SECTION

carnauba wax, ferric oxide red, ferric oxide yellow, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, starch, talc, titanium dioxide

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label ImageLabel Image

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82725-404782725-4047-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215766-001FAMOTIDINEFAMOTIDINE10MGTABLET / ORAL2021-11-08
A215766-002FAMOTIDINEFAMOTIDINE20MGTABLET / ORAL2021-11-08

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 72 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08c2088c7a36db…
2026-10-15 13:18:302026-09A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08c2088c7a36db…
2026-09-14 22:38:342026-08A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-0884e616aacf4f…
2026-09-14 22:38:342026-08A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-0884e616aacf4f…
2026-08-18 06:07:402026-07A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08caaa826d4ba7…
2026-08-18 06:07:402026-07A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-0831067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-086a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-0803ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-0803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-082680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-082680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-085bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-085bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08d06236e962d9…
2024-10-29 15:01 UTC2024-10A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-0879d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-0879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-08301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-08301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-081e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-081e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-088072bd15b7f6…
2024-05-31 18:47 UTC2024-05A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-088072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-085c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-085c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-085d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-085d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A215766-001FAMOTIDINE10MGTABLET / ORAL2021-11-084b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A215766-002FAMOTIDINE20MGTABLET / ORAL2021-11-084b0b4de00fa7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Goodmeds Famotidine 20mg 500 countFAMOTIDINE 20MGCabinet Health P.B.C.5592d0f0-03fd-c914-e063-6294a90a28262026-07-01WarningsExact identifier
ndc (package): 82725-4047-1
ndc (product): 82725-4047
ndc11 (package): 82725404701
spl id: 5592d0f0-03fe-c914-e063-6294a90a2826
spl set id: 5592d0f0-03fd-c914-e063-6294a90a2826

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.